Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic

Detalhes bibliográficos
Autor(a) principal: Pivatto Junior, Fernando
Data de Publicação: 2014
Outros Autores: Silva, André Luis Ferreira da, Rigoni, Lisandra Della Costa, Simionato, Bárbara Marina, Fuzinatto, Fernanda, Oliveira, Jerônimo de Conto, Pires, Leonardo Martins, Petry, Roberta Cristina, Scheffel, Rafael Selbach, Amon, Luis Carlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFRGS
Texto Completo: http://hdl.handle.net/10183/158160
Resumo: INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2DS2-VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies.
id UFRGS-2_2a3f6250c99fdd446c2caa1ef559552e
oai_identifier_str oai:www.lume.ufrgs.br:10183/158160
network_acronym_str UFRGS-2
network_name_str Repositório Institucional da UFRGS
repository_id_str
spelling Pivatto Junior, FernandoSilva, André Luis Ferreira daRigoni, Lisandra Della CostaSimionato, Bárbara MarinaFuzinatto, FernandaOliveira, Jerônimo de ContoPires, Leonardo MartinsPetry, Roberta CristinaScheffel, Rafael SelbachAmon, Luis Carlos2017-05-18T02:41:13Z20142357-9730http://hdl.handle.net/10183/158160000983375INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2DS2-VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies.application/pdfengClinical and biomedical research. Porto Alegre. Vol. 34, n. 2 (2014), p. 139-144AnticoagulantesVarfarinaFemprocumonaFibrilação atrialAnticoagulantsPhenprocoumonWarfarinAtrial fibrillationInternship and residencyManagement of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinicinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSORIGINAL000983375.pdf000983375.pdfTexto completo (inglês)application/pdf365916http://www.lume.ufrgs.br/bitstream/10183/158160/1/000983375.pdf9d67ba1b8c5f135dfd0b1e6126b0b740MD51TEXT000983375.pdf.txt000983375.pdf.txtExtracted Texttext/plain23034http://www.lume.ufrgs.br/bitstream/10183/158160/2/000983375.pdf.txtebad88f997d64f65a63a1d70553b9a8dMD52THUMBNAIL000983375.pdf.jpg000983375.pdf.jpgGenerated Thumbnailimage/jpeg1603http://www.lume.ufrgs.br/bitstream/10183/158160/3/000983375.pdf.jpgd396584040e1507126dc216cb937f21fMD5310183/1581602018-10-30 08:07:22.494oai:www.lume.ufrgs.br:10183/158160Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2018-10-30T11:07:22Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false
dc.title.pt_BR.fl_str_mv Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
title Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
spellingShingle Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
Pivatto Junior, Fernando
Anticoagulantes
Varfarina
Femprocumona
Fibrilação atrial
Anticoagulants
Phenprocoumon
Warfarin
Atrial fibrillation
Internship and residency
title_short Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
title_full Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
title_fullStr Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
title_full_unstemmed Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
title_sort Management of anticoagulation with vitamin K antagonists in a tertiary hospital outpatient clinic
author Pivatto Junior, Fernando
author_facet Pivatto Junior, Fernando
Silva, André Luis Ferreira da
Rigoni, Lisandra Della Costa
Simionato, Bárbara Marina
Fuzinatto, Fernanda
Oliveira, Jerônimo de Conto
Pires, Leonardo Martins
Petry, Roberta Cristina
Scheffel, Rafael Selbach
Amon, Luis Carlos
author_role author
author2 Silva, André Luis Ferreira da
Rigoni, Lisandra Della Costa
Simionato, Bárbara Marina
Fuzinatto, Fernanda
Oliveira, Jerônimo de Conto
Pires, Leonardo Martins
Petry, Roberta Cristina
Scheffel, Rafael Selbach
Amon, Luis Carlos
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pivatto Junior, Fernando
Silva, André Luis Ferreira da
Rigoni, Lisandra Della Costa
Simionato, Bárbara Marina
Fuzinatto, Fernanda
Oliveira, Jerônimo de Conto
Pires, Leonardo Martins
Petry, Roberta Cristina
Scheffel, Rafael Selbach
Amon, Luis Carlos
dc.subject.por.fl_str_mv Anticoagulantes
Varfarina
Femprocumona
Fibrilação atrial
topic Anticoagulantes
Varfarina
Femprocumona
Fibrilação atrial
Anticoagulants
Phenprocoumon
Warfarin
Atrial fibrillation
Internship and residency
dc.subject.eng.fl_str_mv Anticoagulants
Phenprocoumon
Warfarin
Atrial fibrillation
Internship and residency
description INTRODUCTION: Atrial fibrillation (AF) is one of the main risk factors for stroke. Vitamin K antagonists (VKA) reduce this risk, and the effectiveness of this treatment is directly related to time in therapeutic range (TTR). This study aimed to report the TTR in patients with non-valvular AF at an anticoagulation outpatient clinic; and to describe the profile of this population of patients in terms of risk of stroke, as well as the occurrence of adverse events during the follow-up. METHODS: Retrospective cohort study involving patients of the anticoagulation outpatient clinic of the Department of Internal Medicine at Hospital de Clínicas de Porto Alegre. We evaluated outpatient visits, hospital admissions, and emergency visits from January to December 2011. TTR was calculated using the Rosendaal method. RESULTS: Sixty-three patients were investigated. Their mean age was 74.3±10.9 years. The CHADS2 score was ≥ 4 in 44.5% of the patients; 63.5% of them had a CHA2DS2-VASc score ≥ 5. The TTR was 64.8%. During follow-up, the incidence of overall bleeding was 31.7%, with major and minor bleeding rates of 4.8% and 34.9%, respectively. There were no other complications related to AF or anticoagulation. CONCLUSION: The patients achieved a TTR of 64.8% during follow-up, which is deemed appropriate and in agreement with the literature. Patients had high risk for stroke, and the incidence of minor bleeding was higher than the rate found in the literature, whereas the incidence of major bleeding was similar to the one found in previous studies.
publishDate 2014
dc.date.issued.fl_str_mv 2014
dc.date.accessioned.fl_str_mv 2017-05-18T02:41:13Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/other
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10183/158160
dc.identifier.issn.pt_BR.fl_str_mv 2357-9730
dc.identifier.nrb.pt_BR.fl_str_mv 000983375
identifier_str_mv 2357-9730
000983375
url http://hdl.handle.net/10183/158160
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.pt_BR.fl_str_mv Clinical and biomedical research. Porto Alegre. Vol. 34, n. 2 (2014), p. 139-144
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRGS
instname:Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
instname_str Universidade Federal do Rio Grande do Sul (UFRGS)
instacron_str UFRGS
institution UFRGS
reponame_str Repositório Institucional da UFRGS
collection Repositório Institucional da UFRGS
bitstream.url.fl_str_mv http://www.lume.ufrgs.br/bitstream/10183/158160/1/000983375.pdf
http://www.lume.ufrgs.br/bitstream/10183/158160/2/000983375.pdf.txt
http://www.lume.ufrgs.br/bitstream/10183/158160/3/000983375.pdf.jpg
bitstream.checksum.fl_str_mv 9d67ba1b8c5f135dfd0b1e6126b0b740
ebad88f997d64f65a63a1d70553b9a8d
d396584040e1507126dc216cb937f21f
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)
repository.mail.fl_str_mv
_version_ 1801224915602374656